Abstract
Diabetic ketoacidosis (DKA) is a serious, life-threatening complication of diabetes. Although individuals who are at risk for DKA are advised to monitor ketone levels, adherence to monitoring is suboptimal. Continuous ketone monitoring is an emerging technology with the potential to address many of the limitations of current monitoring methods. Abbott Diabetes Care (Alameda, CA) has developed a continuous dual glucose–ketone sensor that measures both interstitial glucose and ketone levels simultaneously, transmitting the information in a continuous stream of data to users. However, one of the challenges in this effort was developing a sensor that can be factory-calibrated to ensure accuracy, safety, and user convenience. This article describes processes realizing factory calibration for the ketone sensor component.
Author supplied keywords
Cite
CITATION STYLE
Hoss, U., Alva, S., Pryor, H., Welsh, Z., & Feldman, B. (2025). Continuous Dual Glucose–Ketone Sensing Technology. Diabetes Technology and Therapeutics, 27, S20–S24. https://doi.org/10.1177/15209156251390820
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.